Insider Transactions in Q2 2024 at Laboratory Corp Of America Holdings (LH)
Insider Transaction List (Q2 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 06
2024
|
Paul Rothman Director |
BUY
Exercise of conversion of derivative security
|
Direct |
717
+50.0%
|
-
|
|
May 14
2024
|
Vaart Sandra D Van Der EVP, Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
2,000
-13.5%
|
$420,000
$210.83 P/Share
|
|
May 02
2024
|
Kerrii B Anderson Director |
SELL
Open market or private sale
|
Direct |
250
-1.57%
|
$50,000
$200.1 P/Share
|
|
Apr 30
2024
|
Kerrii B Anderson Director |
SELL
Open market or private sale
|
Direct |
250
-1.54%
|
$51,000
$204.13 P/Share
|
|
Apr 30
2024
|
Glenn A Eisenberg Executive Vice President |
SELL
Payment of exercise price or tax liability
|
Direct |
4,496
-8.85%
|
$903,696
$201.37 P/Share
|
|
Apr 30
2024
|
Glenn A Eisenberg Executive Vice President |
BUY
Exercise of conversion of derivative security
|
Direct |
10,229
+16.77%
|
-
|
|
Apr 29
2024
|
Peter J Wilkinson SVP, Chief Accounting Officer |
SELL
Open market or private sale
|
Direct |
2,439
-53.89%
|
$497,556
$204.33 P/Share
|
|
Apr 15
2024
|
Glenn A Eisenberg Executive Vice President |
SELL
Payment of exercise price or tax liability
|
Direct |
4,496
-9.98%
|
$912,688
$203.32 P/Share
|
|
Apr 15
2024
|
Glenn A Eisenberg Executive Vice President |
BUY
Exercise of conversion of derivative security
|
Direct |
10,229
+18.5%
|
-
|
|
Apr 01
2024
|
Mark S Schroeder EVP, Pres Diagnostics & COO |
SELL
Open market or private sale
|
Direct |
6,477
-56.26%
|
$1,405,509
$217.29 P/Share
|
|
Apr 01
2024
|
Megan D. Bailey EVP, Pres, Central Labs & Intl |
SELL
Payment of exercise price or tax liability
|
Direct |
69
-13.66%
|
$14,904
$216.35 P/Share
|
|
Apr 01
2024
|
Megan D. Bailey EVP, Pres, Central Labs & Intl |
BUY
Exercise of conversion of derivative security
|
Direct |
205
+28.87%
|
-
|
|
Apr 01
2024
|
Amy B. Summy EVP, Chief Marketing Officer |
SELL
Open market or private sale
|
Direct |
3,500
-46.82%
|
$759,500
$217.29 P/Share
|